Zephyr AI, a Tysons Corner, VA-based high-growth healthcare technology company, closed $18.5 million in a seed round.
The round was led by Lerner Group Investments LLC and M-Cor Holdings, with participation from Allen Y. Chao, AME Cloud Ventures, BoxGroup, MedStar Health, Roger W. Ferguson, Steve Oristaglio, Verily, and other strategic investors.
This capital raise will help Zephyr AI to expand its scope, including curating additional healthcare datasets, refining advanced machine-learning models, and deriving actionable insights for better outcomes in patient care and drug discovery.
Company: Zephyr AI, Inc.
Round: Seed Round
Funding Month: March 2022
Lead Investors: Lerner Group Investments LLC and M-Cor Holdings
Additional Investors: Allen Y. Chao, AME Cloud Ventures, BoxGroup, MedStar Health, Roger W. Ferguson, Steve Oristaglio, and Verily
Company Website: https://www.zephyrai.bio/
Software Category: Drug Discovery
About the Company: Zephyr AI is a high-growth healthcare technology company committed to radically reshaping traditional approaches to drug discovery and precision medicine. Through partnerships and proprietary data, Zephyr AI is curating the world’s most comprehensive healthcare dataset and marrying it with cutting-edge artificial intelligence algorithms to generate novel, translatable insights to build tools and products that support both patients and providers and fuel ongoing research. At Zephyr AI, our mission-focused team of world-class software engineers and biologists leverage big data and cutting-edge technology to derive transformational insights and build enduring partnerships that will revolutionize the treatment of cancer, diabetes, and other diseases.